|Institutional Source||Beutler Lab|
|Gene Name||spalt like transcription factor 1|
|Is this an essential gene?||Probably essential (E-score: 0.945)|
|Stock #||R4085 (G1)|
|Chromosomal Location||89027235-89044162 bp(-) (GRCm38)|
|Type of Mutation||missense|
|DNA Base Change (assembly)||C to T at 89028509 bp|
|Amino Acid Change||Valine to Methionine at position 1281 (V1281M)|
|Ref Sequence||ENSEMBL: ENSMUSP00000034090 (fasta)|
|Gene Model||predicted gene model for transcript(s): [ENSMUST00000034090]|
|Predicted Effect||probably benign
AA Change: V1281M
PolyPhen 2 Score 0.000 (Sensitivity: 1.00; Specificity: 0.00)
AA Change: V1281M
|Predicted Effect||noncoding transcript
|Meta Mutation Damage Score||0.0898|
|Coding Region Coverage||
|Validation Efficiency||98% (59/60)|
FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] The protein encoded by this gene is a zinc finger transcriptional repressor and may be part of the NuRD histone deacetylase complex (HDAC). Defects in this gene are a cause of Townes-Brocks syndrome (TBS) as well as bronchio-oto-renal syndrome (BOR). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PHENOTYPE: Homozygotes for a targeted null mutation exhibit kidney agenesis or dysgenesis and die perinatally. Homozygotes expressing only a truncated protein show renal agenesis, exencephaly, and limb defects; heterozygotes have hearing loss and cystic kidneys. [provided by MGI curators]
|Allele List at MGI|
|Other mutations in this stock||
|Other mutations in Sall1||
(F):5'- TGTAGTTCATAGTCCCAGGGG -3'
(R):5'- ATGTTCCAGAAGGATCTAGCGG -3'
(F):5'- CATAGTCCCAGGGGCCAGAAG -3'
(R):5'- ATCTAGCGGCGAGGTCAG -3'